-
-
-
-
-
-
-
AstraZeneca launches direct-to-consumer platform for US patients
-
-
-
-
-
-
-
AstraZeneca (AZN) Announces Approval of Beyfortus in China
-
-
-
-
-
-
-
AstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022
-
-
-
-
-
-
-
FDA Votes Astrazeneca's (AZN) Roxadustat Benefit-Risk Profile Does Not Support Approval
-
-
-
-
-
-
-
Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
-
-
-
-
-
-
-
AstraZeneca (AZN), Merck (MRK) Announce Lynparza Approved in U.S. for Pancreatic Cancer
-
-
-
-
-
-
-
FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis
-
15,954 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

